Ras Al Khaimah: Pure Health, the leading integrated healthcare solutions provider in the UAE, launched their extended laboratory service offerings at the Ibrahim Bin Hamad Obaidullah Hospital in Ras Al Khaimah to include COVID-19 RT- PCR testing.
Healthcare facilities in and around Ras Al Khaimah can now use the laboratory facilities of the hospital operated by the UAE Ministry of Health and Prevention (MOHAP) located in Al Oraibi area, Ras Al Khaimah, for COVID-19 testing.
“The COVID-19 testing facility is yet another addition to the Ibrahim Obaidullah Hospital’s healthcare services to cater to the citizens and residents of Ras Al Khaimah and nearby areas. With the laboratory’s capacity to run 10,000 COVID-19 RT-PCR tests per day, we can now further support Ras Al Khaima’s healthcare system with the necessary tests and prompt results” said Dr. Yousif Al Tair, Director, Ibrahim Bin Hamad Obaidullah Hospital.
“We have been on the forefront of fighting the pandemic since it originated in 2019. Under the guidance of MOHAP and the Nation’s Leadership, we have ramped up Covid-19 screening and testing across the northern emirates. The launch of this laboratory is our latest contribution to Ras Al Khaimah’s healthcare system. More similar projects to improve the healthcare ecosystem throughout the country are in the pipeline. We are in the process of setting up more Covid-19 RT PCR testing laboratories in the northern region.” said Carlo Kaabar, Medical director, MOHAP Labs at Pure Health.
The COVID-19 testing facility at Ibrahim Bin Hamad Obaidullah Hospital, is set to provide results within 12 hours for inpatients of all RAK hospitals and 24 hours for screening samples.
“Considering the urgent nature of inpatient testing, the laboratory uses advanced analytics within its laboratory information system to prioritise inpatient samples against screening samples. The laboratory uses state-of-the-art, automated laboratory analyzers with advanced laboratory information systems to connect with other facilities, such as hospitals, PMDs, PHCs, government entities to report the results” Carlo added.
Earlier, Pure Health had installed one of the world’s most advanced diagnostic systems in the region, Aptio 2 Robotic Automation System, at the laboratory of Ibrahim Bin Hamad Obaidullah Hospital. The installation of this system has made Obaidullah Hospital the central reference location point for all laboratories in Ras Al Khaimah.
Pure Health is a specialist in healthcare services and technology, facilitating healthcare organisations to run more efficiently. Pure Health partners with hospitals, integrated healthcare systems, healthcare suppliers, the Federal Government, and others across the spectrum of care to build health facilities that deliver better care to patients in every setting.
Since 2017, Pure Health has been operating all medical and diagnostic laboratories of MOHAP hospitals under a partnership agreement with the ministry. The partnership started with 11 laboratories and now Pure Health manages over 150 laboratory facilities in the UAE.
-Ends-
About Pure Health
Pure Health is an integrated healthcare solutions provider with a diversified services portfolio of hospital management, laboratory services, and medical solutions, helping people live a healthier life through a new standard of healthcare.
Pure Health manages a network of eight hospitals, and over 150 laboratories (the region’s largest network). Pure Health drives the growing healthcare ecosystem by supplying medical and diagnostic devices to a customer base of over 300 healthcare providers offering them customised solutions towards improvement of financial, operational, and clinical performance.
Pure Health has been at the forefront of fighting the COVID-19 pandemic through providing screenings and vaccine administration to UAE citizens and residents.
For more information, visit purehealth.ae or write to mohamed.mostafa@purehealth.ae. You can also follow Pure Health on Facebook, Twitter, Instagram and LinkedIn.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
